199 related articles for article (PubMed ID: 7524803)
1. A case of hepatocellular carcinoma that resisted identification.
Cristani A; Cioni G; De Santis M; Vignoli A; Sardini C; Tincani E; Ventura E
Ital J Gastroenterol; 1994; 26(6):303-5. PubMed ID: 7524803
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
[TBL] [Abstract][Full Text] [Related]
3. Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
Cardiovasc Intervent Radiol; 2006; 29(6):1111-3. PubMed ID: 16933161
[TBL] [Abstract][Full Text] [Related]
4. Utility of sonography in diagnosing hepatocellular carcinoma.
Tarantino G
AJR Am J Roentgenol; 2007 May; 188(5):W494; author reply W495. PubMed ID: 17449752
[No Abstract] [Full Text] [Related]
5. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
Shinagawa T; Ohto M; Kimura K; Tsunetomi S; Morita M; Saisho H; Tsuchiya Y; Saotome N; Karasawa E; Miki M
Gastroenterology; 1984 Mar; 86(3):495-502. PubMed ID: 6198238
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of scintigraphy, CT and serum alpha-fetoprotein in patients with hepatocellular carcinoma].
Ono S; Hoshi H; Jinnouchi M; Tsukino H; Wakuta Y; Watanake K
Rinsho Hoshasen; 1986 Dec; 31(13):1521-5. PubMed ID: 2434693
[No Abstract] [Full Text] [Related]
8. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: update on diagnosis and treatment.
Ramsey WH; Wu GY
Dig Dis; 1995; 13(2):81-91. PubMed ID: 7586635
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis of hepatocellular carcinoma.
Okazaki N; Yoshino M; Yoshida T; Takayasu K; Moriyama N; Makuuchi M; Yamazaki S; Hasegawa H; Noguchi M; Hirohashi S
Hepatogastroenterology; 1990 Oct; 37(5):480-3. PubMed ID: 1701411
[TBL] [Abstract][Full Text] [Related]
11. Imaging of hepatocellular carcinoma: current concepts.
Parikh A; Taouli B
Recent Results Cancer Res; 2013; 190():33-55. PubMed ID: 22941012
[TBL] [Abstract][Full Text] [Related]
12. Multilocular cystic hepatocellular carcinoma.
Ohtomo K; Furui S; Iio M; Kodama T; Iwasaki Y; Takaku F
Radiat Med; 1984; 2(3):164-6. PubMed ID: 6100460
[TBL] [Abstract][Full Text] [Related]
13. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
[TBL] [Abstract][Full Text] [Related]
14. [Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol].
Mlinarić B
Lijec Vjesn; 2000; 122(1-2):6-8. PubMed ID: 10916349
[TBL] [Abstract][Full Text] [Related]
15. [Hemoperitoneum supporting difficult diagnosis of diffuse hepatocarcinoma in liver cirrhosis].
Vignoli A; Cioni G; Sardini C; Tincani E; Cristani A; Ventura E
Recenti Prog Med; 1994 Apr; 85(4):235-7. PubMed ID: 7517061
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma of small size.
Watanabe A; Sakata T; Shiota T; Nagashima H
Am J Med Sci; 1984 Nov; 288(4):151-7. PubMed ID: 6208779
[TBL] [Abstract][Full Text] [Related]
17. Transient spontaneous regression of hepatocellular carcinoma.
Magalotti D; Gueli C; Zoli M
Hepatogastroenterology; 1998; 45(24):2369-71. PubMed ID: 9951925
[TBL] [Abstract][Full Text] [Related]
18. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
Kilickap S; Arslan C; Senel S; Ataseven H
J Clin Oncol; 2010 Feb; 28(6):e99; author reply e100. PubMed ID: 20085931
[No Abstract] [Full Text] [Related]
20. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection.
Bartolozzi C; Lencioni R; Caramella D; Falaschi F; Cioni R; DiCoscio G
Radiology; 1994 Apr; 191(1):123-8. PubMed ID: 8134557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
